The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Amlodipine Besylate Tablets Market Research Report 2024
Synopsis
Amlodipine besylate is a dihydropyridine calcium channel antagonist, which can selectively inhibit cell membrane calcium ion channels, act on smooth muscle cells and cardiomyocytes, effectively regulate intracellular calcium levels, and enable normal physiological functions. Maintain, thereby dilate the coronary blood vessels and the blood vessels of the whole body, and lower blood pressure. Clinically, it is generally used to treat hypertensive coronary heart disease and essential hypertension. Amlodipine can be used alone or in combination with other antihypertensive drugs, chronic stable angina and variant angina.
The global Amlodipine Besylate Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Amlodipine Besylate Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amlodipine Besylate Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amlodipine Besylate Tablets include China Resources Double-Crane Pharmaceutical, Pfizer, North China Pharmaceutical, AstraZeneca, Sanofi, Roche, Bristol-Myers Squibb, Yangtze River Pharmaceutical and Shanghai Shyndec Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Amlodipine Besylate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amlodipine Besylate Tablets.
Report Scope
The Amlodipine Besylate Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amlodipine Besylate Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
China Resources Double-Crane Pharmaceutical
Pfizer
North China Pharmaceutical
AstraZeneca
Sanofi
Roche
Bristol-Myers Squibb
Yangtze River Pharmaceutical
Shanghai Shyndec Pharmaceutical
Jingfeng Pharmaceutical
Segment by Type
5 Milligrams
10 Milligrams
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amlodipine Besylate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amlodipine Besylate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Amlodipine besylate is a dihydropyridine calcium channel antagonist, which can selectively inhibit cell membrane calcium ion channels, act on smooth muscle cells and cardiomyocytes, effectively regulate intracellular calcium levels, and enable normal physiological functions. Maintain, thereby dilate the coronary blood vessels and the blood vessels of the whole body, and lower blood pressure. Clinically, it is generally used to treat hypertensive coronary heart disease and essential hypertension. Amlodipine can be used alone or in combination with other antihypertensive drugs, chronic stable angina and variant angina.
The global Amlodipine Besylate Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Amlodipine Besylate Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amlodipine Besylate Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amlodipine Besylate Tablets include China Resources Double-Crane Pharmaceutical, Pfizer, North China Pharmaceutical, AstraZeneca, Sanofi, Roche, Bristol-Myers Squibb, Yangtze River Pharmaceutical and Shanghai Shyndec Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Amlodipine Besylate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amlodipine Besylate Tablets.
Report Scope
The Amlodipine Besylate Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amlodipine Besylate Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
China Resources Double-Crane Pharmaceutical
Pfizer
North China Pharmaceutical
AstraZeneca
Sanofi
Roche
Bristol-Myers Squibb
Yangtze River Pharmaceutical
Shanghai Shyndec Pharmaceutical
Jingfeng Pharmaceutical
Segment by Type
5 Milligrams
10 Milligrams
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amlodipine Besylate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amlodipine Besylate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Amlodipine Besylate Tablets Market Overview
1.1 Product Overview and Scope of Amlodipine Besylate Tablets
1.2 Amlodipine Besylate Tablets Segment by Type
1.2.1 Global Amlodipine Besylate Tablets Market Value Comparison by Type (2024-2030)
1.2.2 5 Milligrams
1.2.3 10 Milligrams
1.3 Amlodipine Besylate Tablets Segment by Application
1.3.1 Global Amlodipine Besylate Tablets Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Amlodipine Besylate Tablets Market Size Estimates and Forecasts
1.4.1 Global Amlodipine Besylate Tablets Revenue 2019-2030
1.4.2 Global Amlodipine Besylate Tablets Sales 2019-2030
1.4.3 Global Amlodipine Besylate Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amlodipine Besylate Tablets Market Competition by Manufacturers
2.1 Global Amlodipine Besylate Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amlodipine Besylate Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amlodipine Besylate Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Amlodipine Besylate Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amlodipine Besylate Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amlodipine Besylate Tablets, Product Type & Application
2.7 Amlodipine Besylate Tablets Market Competitive Situation and Trends
2.7.1 Amlodipine Besylate Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amlodipine Besylate Tablets Players Market Share by Revenue
2.7.3 Global Amlodipine Besylate Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amlodipine Besylate Tablets Retrospective Market Scenario by Region
3.1 Global Amlodipine Besylate Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amlodipine Besylate Tablets Global Amlodipine Besylate Tablets Sales by Region: 2019-2030
3.2.1 Global Amlodipine Besylate Tablets Sales by Region: 2019-2024
3.2.2 Global Amlodipine Besylate Tablets Sales by Region: 2025-2030
3.3 Global Amlodipine Besylate Tablets Global Amlodipine Besylate Tablets Revenue by Region: 2019-2030
3.3.1 Global Amlodipine Besylate Tablets Revenue by Region: 2019-2024
3.3.2 Global Amlodipine Besylate Tablets Revenue by Region: 2025-2030
3.4 North America Amlodipine Besylate Tablets Market Facts & Figures by Country
3.4.1 North America Amlodipine Besylate Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amlodipine Besylate Tablets Sales by Country (2019-2030)
3.4.3 North America Amlodipine Besylate Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Amlodipine Besylate Tablets Market Facts & Figures by Country
3.5.1 Europe Amlodipine Besylate Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amlodipine Besylate Tablets Sales by Country (2019-2030)
3.5.3 Europe Amlodipine Besylate Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amlodipine Besylate Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Amlodipine Besylate Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amlodipine Besylate Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Amlodipine Besylate Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Amlodipine Besylate Tablets Market Facts & Figures by Country
3.7.1 Latin America Amlodipine Besylate Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amlodipine Besylate Tablets Sales by Country (2019-2030)
3.7.3 Latin America Amlodipine Besylate Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amlodipine Besylate Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Amlodipine Besylate Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amlodipine Besylate Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amlodipine Besylate Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amlodipine Besylate Tablets Sales by Type (2019-2030)
4.1.1 Global Amlodipine Besylate Tablets Sales by Type (2019-2024)
4.1.2 Global Amlodipine Besylate Tablets Sales by Type (2025-2030)
4.1.3 Global Amlodipine Besylate Tablets Sales Market Share by Type (2019-2030)
4.2 Global Amlodipine Besylate Tablets Revenue by Type (2019-2030)
4.2.1 Global Amlodipine Besylate Tablets Revenue by Type (2019-2024)
4.2.2 Global Amlodipine Besylate Tablets Revenue by Type (2025-2030)
4.2.3 Global Amlodipine Besylate Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Amlodipine Besylate Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Amlodipine Besylate Tablets Sales by Application (2019-2030)
5.1.1 Global Amlodipine Besylate Tablets Sales by Application (2019-2024)
5.1.2 Global Amlodipine Besylate Tablets Sales by Application (2025-2030)
5.1.3 Global Amlodipine Besylate Tablets Sales Market Share by Application (2019-2030)
5.2 Global Amlodipine Besylate Tablets Revenue by Application (2019-2030)
5.2.1 Global Amlodipine Besylate Tablets Revenue by Application (2019-2024)
5.2.2 Global Amlodipine Besylate Tablets Revenue by Application (2025-2030)
5.2.3 Global Amlodipine Besylate Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Amlodipine Besylate Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 China Resources Double-Crane Pharmaceutical
6.1.1 China Resources Double-Crane Pharmaceutical Corporation Information
6.1.2 China Resources Double-Crane Pharmaceutical Description and Business Overview
6.1.3 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.1.5 China Resources Double-Crane Pharmaceutical Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Amlodipine Besylate Tablets Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 North China Pharmaceutical
6.3.1 North China Pharmaceutical Corporation Information
6.3.2 North China Pharmaceutical Description and Business Overview
6.3.3 North China Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 North China Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.3.5 North China Pharmaceutical Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca Amlodipine Besylate Tablets Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Amlodipine Besylate Tablets Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Roche Amlodipine Besylate Tablets Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bristol-Myers Squibb Amlodipine Besylate Tablets Product Portfolio
6.7.5 Bristol-Myers Squibb Recent Developments/Updates
6.8 Yangtze River Pharmaceutical
6.8.1 Yangtze River Pharmaceutical Corporation Information
6.8.2 Yangtze River Pharmaceutical Description and Business Overview
6.8.3 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.8.5 Yangtze River Pharmaceutical Recent Developments/Updates
6.9 Shanghai Shyndec Pharmaceutical
6.9.1 Shanghai Shyndec Pharmaceutical Corporation Information
6.9.2 Shanghai Shyndec Pharmaceutical Description and Business Overview
6.9.3 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.9.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
6.10 Jingfeng Pharmaceutical
6.10.1 Jingfeng Pharmaceutical Corporation Information
6.10.2 Jingfeng Pharmaceutical Description and Business Overview
6.10.3 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.10.5 Jingfeng Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amlodipine Besylate Tablets Industry Chain Analysis
7.2 Amlodipine Besylate Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amlodipine Besylate Tablets Production Mode & Process
7.4 Amlodipine Besylate Tablets Sales and Marketing
7.4.1 Amlodipine Besylate Tablets Sales Channels
7.4.2 Amlodipine Besylate Tablets Distributors
7.5 Amlodipine Besylate Tablets Customers
8 Amlodipine Besylate Tablets Market Dynamics
8.1 Amlodipine Besylate Tablets Industry Trends
8.2 Amlodipine Besylate Tablets Market Drivers
8.3 Amlodipine Besylate Tablets Market Challenges
8.4 Amlodipine Besylate Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Amlodipine Besylate Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Amlodipine Besylate Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Amlodipine Besylate Tablets Market Competitive Situation by Manufacturers in 2023
Table 4. Global Amlodipine Besylate Tablets Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Amlodipine Besylate Tablets Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Amlodipine Besylate Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Amlodipine Besylate Tablets Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Amlodipine Besylate Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Amlodipine Besylate Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Amlodipine Besylate Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amlodipine Besylate Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Amlodipine Besylate Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amlodipine Besylate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amlodipine Besylate Tablets as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amlodipine Besylate Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Amlodipine Besylate Tablets Sales by Region (2019-2024) & (K Units)
Table 18. Global Amlodipine Besylate Tablets Sales Market Share by Region (2019-2024)
Table 19. Global Amlodipine Besylate Tablets Sales by Region (2025-2030) & (K Units)
Table 20. Global Amlodipine Besylate Tablets Sales Market Share by Region (2025-2030)
Table 21. Global Amlodipine Besylate Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Amlodipine Besylate Tablets Revenue Market Share by Region (2019-2024)
Table 23. Global Amlodipine Besylate Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Amlodipine Besylate Tablets Revenue Market Share by Region (2025-2030)
Table 25. North America Amlodipine Besylate Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Amlodipine Besylate Tablets Sales by Country (2019-2024) & (K Units)
Table 27. North America Amlodipine Besylate Tablets Sales by Country (2025-2030) & (K Units)
Table 28. North America Amlodipine Besylate Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Amlodipine Besylate Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Amlodipine Besylate Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Amlodipine Besylate Tablets Sales by Country (2019-2024) & (K Units)
Table 32. Europe Amlodipine Besylate Tablets Sales by Country (2025-2030) & (K Units)
Table 33. Europe Amlodipine Besylate Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Amlodipine Besylate Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Amlodipine Besylate Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Amlodipine Besylate Tablets Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Amlodipine Besylate Tablets Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Amlodipine Besylate Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Amlodipine Besylate Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Amlodipine Besylate Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Amlodipine Besylate Tablets Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Amlodipine Besylate Tablets Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Amlodipine Besylate Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Amlodipine Besylate Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Amlodipine Besylate Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Amlodipine Besylate Tablets Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Amlodipine Besylate Tablets Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Amlodipine Besylate Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Amlodipine Besylate Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Amlodipine Besylate Tablets Sales (K Units) by Type (2019-2024)
Table 51. Global Amlodipine Besylate Tablets Sales (K Units) by Type (2025-2030)
Table 52. Global Amlodipine Besylate Tablets Sales Market Share by Type (2019-2024)
Table 53. Global Amlodipine Besylate Tablets Sales Market Share by Type (2025-2030)
Table 54. Global Amlodipine Besylate Tablets Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Amlodipine Besylate Tablets Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Amlodipine Besylate Tablets Revenue Market Share by Type (2019-2024)
Table 57. Global Amlodipine Besylate Tablets Revenue Market Share by Type (2025-2030)
Table 58. Global Amlodipine Besylate Tablets Price (US$/Unit) by Type (2019-2024)
Table 59. Global Amlodipine Besylate Tablets Price (US$/Unit) by Type (2025-2030)
Table 60. Global Amlodipine Besylate Tablets Sales (K Units) by Application (2019-2024)
Table 61. Global Amlodipine Besylate Tablets Sales (K Units) by Application (2025-2030)
Table 62. Global Amlodipine Besylate Tablets Sales Market Share by Application (2019-2024)
Table 63. Global Amlodipine Besylate Tablets Sales Market Share by Application (2025-2030)
Table 64. Global Amlodipine Besylate Tablets Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Amlodipine Besylate Tablets Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Amlodipine Besylate Tablets Revenue Market Share by Application (2019-2024)
Table 67. Global Amlodipine Besylate Tablets Revenue Market Share by Application (2025-2030)
Table 68. Global Amlodipine Besylate Tablets Price (US$/Unit) by Application (2019-2024)
Table 69. Global Amlodipine Besylate Tablets Price (US$/Unit) by Application (2025-2030)
Table 70. China Resources Double-Crane Pharmaceutical Corporation Information
Table 71. China Resources Double-Crane Pharmaceutical Description and Business Overview
Table 72. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product
Table 74. China Resources Double-Crane Pharmaceutical Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer Amlodipine Besylate Tablets Product
Table 79. Pfizer Recent Developments/Updates
Table 80. North China Pharmaceutical Corporation Information
Table 81. North China Pharmaceutical Description and Business Overview
Table 82. North China Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. North China Pharmaceutical Amlodipine Besylate Tablets Product
Table 84. North China Pharmaceutical Recent Developments/Updates
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. AstraZeneca Amlodipine Besylate Tablets Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sanofi Amlodipine Besylate Tablets Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Roche Corporation Information
Table 96. Roche Description and Business Overview
Table 97. Roche Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Roche Amlodipine Besylate Tablets Product
Table 99. Roche Recent Developments/Updates
Table 100. Bristol-Myers Squibb Corporation Information
Table 101. Bristol-Myers Squibb Description and Business Overview
Table 102. Bristol-Myers Squibb Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Bristol-Myers Squibb Amlodipine Besylate Tablets Product
Table 104. Bristol-Myers Squibb Recent Developments/Updates
Table 105. Yangtze River Pharmaceutical Corporation Information
Table 106. Yangtze River Pharmaceutical Description and Business Overview
Table 107. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product
Table 109. Yangtze River Pharmaceutical Recent Developments/Updates
Table 110. Shanghai Shyndec Pharmaceutical Corporation Information
Table 111. Shanghai Shyndec Pharmaceutical Description and Business Overview
Table 112. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product
Table 114. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
Table 115. Jingfeng Pharmaceutical Corporation Information
Table 116. Jingfeng Pharmaceutical Description and Business Overview
Table 117. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product
Table 119. Jingfeng Pharmaceutical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Amlodipine Besylate Tablets Distributors List
Table 123. Amlodipine Besylate Tablets Customers List
Table 124. Amlodipine Besylate Tablets Market Trends
Table 125. Amlodipine Besylate Tablets Market Drivers
Table 126. Amlodipine Besylate Tablets Market Challenges
Table 127. Amlodipine Besylate Tablets Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Amlodipine Besylate Tablets
Figure 2. Global Amlodipine Besylate Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Amlodipine Besylate Tablets Market Share by Type in 2023 & 2030
Figure 4. 5 Milligrams Product Picture
Figure 5. 10 Milligrams Product Picture
Figure 6. Global Amlodipine Besylate Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Amlodipine Besylate Tablets Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global Amlodipine Besylate Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Amlodipine Besylate Tablets Market Size (2019-2030) & (US$ Million)
Figure 12. Global Amlodipine Besylate Tablets Sales (2019-2030) & (K Units)
Figure 13. Global Amlodipine Besylate Tablets Average Price (US$/Unit) & (2019-2030)
Figure 14. Amlodipine Besylate Tablets Report Years Considered
Figure 15. Amlodipine Besylate Tablets Sales Share by Manufacturers in 2023
Figure 16. Global Amlodipine Besylate Tablets Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Amlodipine Besylate Tablets Players: Market Share by Revenue in 2023
Figure 18. Amlodipine Besylate Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Amlodipine Besylate Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Amlodipine Besylate Tablets Sales Market Share by Country (2019-2030)
Figure 21. North America Amlodipine Besylate Tablets Revenue Market Share by Country (2019-2030)
Figure 22. United States Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Amlodipine Besylate Tablets Sales Market Share by Country (2019-2030)
Figure 25. Europe Amlodipine Besylate Tablets Revenue Market Share by Country (2019-2030)
Figure 26. Germany Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Amlodipine Besylate Tablets Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Amlodipine Besylate Tablets Revenue Market Share by Region (2019-2030)
Figure 33. China Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Amlodipine Besylate Tablets Sales Market Share by Country (2019-2030)
Figure 43. Latin America Amlodipine Besylate Tablets Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Amlodipine Besylate Tablets Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Amlodipine Besylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Amlodipine Besylate Tablets by Type (2019-2030)
Figure 53. Global Revenue Market Share of Amlodipine Besylate Tablets by Type (2019-2030)
Figure 54. Global Amlodipine Besylate Tablets Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Amlodipine Besylate Tablets by Application (2019-2030)
Figure 56. Global Revenue Market Share of Amlodipine Besylate Tablets by Application (2019-2030)
Figure 57. Global Amlodipine Besylate Tablets Price (US$/Unit) by Application (2019-2030)
Figure 58. Amlodipine Besylate Tablets Value Chain
Figure 59. Amlodipine Besylate Tablets Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
